Clinical Trial Update: Melatonin for Neuroprotection Following Perinatal Asphyxia [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluated melatonin for neuroprotection after perinatal asphyxia and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perinatal Asphyxia

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Tanta University | Conditions: Perinatal Asphyxia | Phase 1, Phase 2 | Status: COMPLETED